Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy

Elisa Becze, BA, ELS, Editor
Voice

Description

Combination treatment with an oncolytic virus plus a PD-1 inhibitor shows promise in patients with nonmelanoma skin cancers, researchers reported in early study results during the 2022 Multidisciplinary Head and Neck Cancers Symposium.

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles